Error: Could not add to watchlist. X
+ Watchlist

Credit Suisse Lux Global Biotech Innovators Equity Fund

CLABI1B:LX
518.57
USD
4.36
0.83%
As of 12:59 AM EDT 9/21/2017
Fund Type
SICAV
52Wk Range
366.42 - 529.68
1 Yr Return
16.37%
YTD Return
31.14%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
522.93
52Wk Range
366.42 - 529.68
1 Yr Return
16.28%
YTD Return
31.14%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 09/21/2017)
518.57
Total Assets (m USD) (on 09/21/2017)
173.238
Inception Date
10/05/2001
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
THOMAS AMREIN
Front Load Fee
3.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.90%
Expense Ratio
1.17%
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
Address
Credit Suisse AG
Kalanderplatz 1
8070 Zurich
Switzerland
Tel: +41 44 333 40 50
Phone
-